BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:38 PM
 | 
Sep 24, 2012
 |  BC Extra  |  Company News

Covidien to acquire CNS Therapeutics

Mallinckrodt Inc., the pharma business of Covidien plc (NYSE:COV), will acquire specialty pharma

Read the full 56 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >